Cardiovascular disease risk reduction in patients with diabetes - Is clinical practice effective?

Practical Diabetes International

Volumn 17, Issue 5, 2000, Pages 155-158

  Masding, M G ^a   Martch, F M ^b   Cove, D H ^b  

^a DORSET COUNTY HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Cardiovascular disease risk; Diabetes mellitus

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CONTROL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

EID: 0033847978     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/1528-252X(200007/08)17:5<155::AID-PDI56>3.0.CO;2-A     Document Type: Article

References (10)

1. Diabetes and cardiovascular disease - The Framingham Study
2. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
5. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia
6. Prevention of coronary heart disease in clinical practice - Recommendations of the task force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
7. Targeting lipid lowering drug therapy for primary prevention of coronary disease: An updated Sheffield table
8. An updated coronary risk profile - A statement for health professionals
9. Computerisation of annual clinical review data; A novel approach incorporating data collection and entry into routine clinic practice
10. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events)